Guangshengtang: Covid oral drug GST-HG171 was approved for clinical trials
Guangshengtang: Covid oral drug GST-HG171 was approved for clinical trials https://whatchinareads.com/article/?uid=0dcefed43cfc11ed99bcc7030b3aab5e
2022-09-26: [Article Link] Final update: 2022-09-25 21:55:24
According to the WeChat No. “Hongsong Hall Services”, on 25 September, the Anti-Covid-19 oral drug project, developed by the controlled subsidiary of the listed company Hirosheng Hall, was officially entered into the clinical trial phase with the approval of the National
Please
sign in to continue reading and access original article links of locked articles.
Subscribe now for full access.